Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-09-12)Premium Content

Regeneron Pharmaceuticals Inc (REGN)

2014-09-19@12:18:53 ET
Regeneron Pharmaceuticals (REGN) Trading Near $355.31 Support Level (FBM)

2014-09-19@12:07:42 ET
Shares of REGN Up 18.8% Since Uptrend Call on Shares (PSM)

2014-09-19@06:25:19 ET
Form 4: Update Filing for Regeneron Pharmaceuticals Inc (REGN) (VKR)

2014-09-18@14:28:41 ET
Regeneron Pharmaceuticals (REGN) Showing Resistance Near $364.69 (FBM)

2014-09-18@10:04:41 ET
Regeneron receives FDA breakthrough therapy designation for DME medication (DTM)

2014-09-18@09:30:00 ET
The Zacks Analyst Blog Highlights:Google, Facebook, Apple, Microsoft and Regeneron Pharmaceuticals (PRN)

2014-09-18@07:30:04 ET
Recombinant Therapeutic Proteins Market & Pipeline Analysis 2014 (MTO)

2014-09-18@05:19:25 ET
Form 144: Filing to Sell 29554 Shares of Regeneron Pharmaceuticals In (REGN) (VKR)

2014-09-18@04:56:45 ET
Form 144: Filing to Sell 10328 Shares of Regeneron Pharmaceuticals In (REGN) (VKR)

2014-09-17@08:11:17 ET
Potential Regeneron Pharmaceuticals (REGN) Trade Has 5.63% Downside Protection (FBM)

2014-09-17@07:08:36 ET
Form 4: Update Filing for Regeneron Pharmaceuticals Inc (REGN) (VKR)

2014-09-17@07:08:26 ET
Form 4: Update Filing for Regeneron Pharmaceuticals Inc (REGN) (VKR)

2014-09-17@06:28:11 ET
Regeneron Pharmaceuticals' EYLEA Injection wins US FDA's Breakthrough Therapy designation for diabetic retinopathy in diabetic macular edema patients (MTO)

2014-09-16@17:12:18 ET
Regeneron Pharmaceuticals Set to Possibly Pullback After Yesterday's Rally of 2.73% (PSM)

2014-09-16@13:39:48 ET
Shares of Regeneron Pharmaceuticals Receive a Boost, Up 2.1% (F77)

2014-09-16@11:31:33 ET
Regeneron Pharmaceuticals (REGN) Showing Bullish Technicals With Support At $337.53 (FBM)

2014-09-16@09:11:24 ET
US Stocks Seen Opening Lower as Investors Sit on the Fence Ahead of Federal Policy Announcement (MID)